Facebook, Twitter, blogs and chat rooms provide firms with a quick and nimble vehicle to reach potential and current customers to promote their products.  Delivering a promotional message is cost efficient and ideally create a viral buzz or interactive forum that exponentially multiples a message.   The format, content and technology seem like a marketing departments dream.  That is not the case for regulatory affairs managers.  Using social media to promote a product is more like a swamp of regulatory uncertainty.  The FDA’s regulation of social media and promotional speech is not clear and in legal limbo.  So how do firm’s stay out of FDA’s swamp?   Marketing departments and regulatory affairs managers need common criteria to make decisions that are meaningful for their business.  

This webinar will provide pointers on the basic and subtle ways to manage your marketing activity and gauge what regulatory risks your business is willing to accept.  You will learn how marketing directors, regulatory affairs managers and consultants can chart a path with some sense avoiding regulatory quicksand.  The details of each product become critical in terms of how far you can take advantage of social media.  What you say or don’t say and how you say it can lead trouble.  How you clear up misinformation must follow a very narrow line of thinking. How you maneuver through a website or interact with customers is under FDA scrutiny.  The webinar will provide information that can help you chart your own promotional path through social media. 

With information from this webinar, you can step back and rationally evaluate your firm’s regulatory program for promoting your products via social media.  You will find out what you should do and what you should not do  in order to lower the risks of the FDA saying you violated the law.